Takeda Pharmaceutical Company Limited
4502
Rang in aandelen
#375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Aandeelprijs
$40.45
Marktkapitalisatie
$64.36B
Verandering (1 dag)
1.19%
Verandering (1 jaar)
43.11%
Land
JP
Handel Takeda Pharmaceutical Company Limited (4502)
Categorie
Healthcare
Koersgeschiedenis voor Takeda Pharmaceutical Company Limited (4502)
Hoogste slotkoers: $38.84 op 2026-10-01
Laagste slotkoers: $15.37 op 1990-01-01
Laagste slotkoers: $15.37 op 1990-01-01
Koersgeschiedenis van Takeda Pharmaceutical Company Limited van 1990 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 16.58% |
| 2025 | 9.81% |
| 2024 | -4.74% |
| 2023 | -6.93% |
| 2022 | 10.67% |
| 2021 | -25.73% |
| 2020 | -8.85% |
| 2019 | 17.44% |
| 2018 | -38.14% |
| 2017 | 35.62% |
| 2016 | -15.67% |
| 2015 | 15.94% |
| 2014 | -13.88% |
| 2013 | 6.22% |
| 2012 | 10.14% |
| 2011 | -12.31% |
| 2010 | 13.40% |
| 2009 | -15.52% |
| 2008 | -16.70% |
| 2007 | -10.91% |
| 2006 | 20.85% |
| 2005 | 12.27% |
| 2004 | 25.62% |
| 2003 | -3.39% |
| 2002 | -8.53% |
| 2001 | -25.89% |
| 2000 | 8.44% |
| 1999 | 100.05% |
| 1998 | 14.68% |
| 1997 | 57.21% |
| 1996 | 45.92% |
| 1995 | 33.20% |
| 1994 | 4.32% |
| 1993 | -8.10% |
| 1992 | -2.51% |
| 1991 | -23.26% |
| 1990 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $164.02 | 22.66% |
DE
|
|
| $223.71 | 30.64% |
CH
|
|
| $18.43 | -4.03% |
IN
|
|
| $6.89 | -24.78% |
CN
|
